{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:51:37Z","timestamp":1793364697545,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00417-020-04699-4","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T01:02:17Z","timestamp":1588122137000},"page":"1395-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections"],"prefix":"10.1007","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-7126","authenticated-orcid":false,"given":"A.","family":"Martel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nahon-Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Almairac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baillif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"issue":"9652","key":"4699_CR1","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","volume":"372","author":"HR Coleman","year":"2008","unstructured":"Coleman HR, Chan C-C, Ferris FL et al (2008) Age-related macular degeneration. Lancet Lond Engl 372(9652):1835\u20131845","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"4699_CR2","first-page":"510","volume":"28","author":"P Osaadon","year":"2014","unstructured":"Osaadon P, Fagan XJ, Lifshitz T et al (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye Lond Engl 28(5):510\u2013520","journal-title":"Eye Lond Engl"},{"issue":"6","key":"4699_CR3","first-page":"546","volume":"6","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Mieler WF (2017) Update on the use of anti-VEGF Intravitreal therapies for retinal vein occlusions. Asia-Pac J Ophthalmol Phila Pa 6(6):546\u2013553","journal-title":"Asia-Pac J Ophthalmol Phila Pa"},{"issue":"9","key":"4699_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.ophtha.2015.05.010","volume":"122","author":"MC Gillies","year":"2015","unstructured":"Gillies MC, Campain A, Barthelmes D et al (2015) Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study. Ophthalmology. 122(9):1837\u20131845","journal-title":"Ophthalmology."},{"issue":"4","key":"4699_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.7647","volume":"132","author":"FA Sloan","year":"2014","unstructured":"Sloan FA, Hanrahan BW (2014) The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration. JAMA Ophthalmol 132(4):456\u2013463","journal-title":"JAMA Ophthalmol"},{"issue":"20","key":"4699_CR6","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1001\/jama.2017.4568","volume":"317","author":"IU Scott","year":"2017","unstructured":"Scott IU, VanVeldhuisen PC, Ip MS et al (2017) Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial. JAMA. 317(20):2072\u20132087","journal-title":"JAMA."},{"issue":"8","key":"4699_CR7","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF et al (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 123(8):1751\u20131761","journal-title":"Ophthalmology."},{"issue":"1","key":"4699_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00417-016-3431-x","volume":"255","author":"N Eter","year":"2017","unstructured":"Eter N, Mohr A, Wachtlin J et al (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 255(1):77\u201387","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"10","key":"4699_CR9","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 121(10):1904\u20131914","journal-title":"Ophthalmology."},{"key":"4699_CR10","doi-asserted-by":"crossref","unstructured":"Mitchell J, Bradley C (2006) Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes 21 4:97","DOI":"10.1186\/1477-7525-4-97"},{"issue":"2","key":"4699_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ajo.2004.09.028","volume":"139","author":"GH Berdeaux","year":"2005","unstructured":"Berdeaux GH, Nordmann J-P, Colin E et al (2005) Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol 139(2):271\u2013279","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"4699_CR12","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1167\/iovs.16-19729","volume":"57","author":"C Aroney","year":"2016","unstructured":"Aroney C, Fraser-Bell S, Lamoureux EL et al (2016) Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 57(13):5541\u20135546","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4699_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/OPTH.S100168","volume":"10","author":"S Sivaprasad","year":"2016","unstructured":"Sivaprasad S, Oyetunde S (2016) Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion. Clin Ophthalmol Auckl NZ 10:939\u2013946","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"4699_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2415-14-78","volume":"14","author":"SR Dawson","year":"2014","unstructured":"Dawson SR, Mallen CD, Gouldstone MB et al (2014) The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol 14:78","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"4699_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/bjo.2003.037788","volume":"88","author":"MD Nijkamp","year":"2004","unstructured":"Nijkamp MD, Kenens CA, Dijker AJM et al (2004) Determinants of surgery related anxiety in cataract patients. Br J Ophthalmol 88(10):1310\u20131314","journal-title":"Br J Ophthalmol"},{"key":"4699_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajo.2017.03.005","volume":"177","author":"H Senra","year":"2017","unstructured":"Senra H, Balaskas K, Mahmoodi N et al (2017) Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. Am J Ophthalmol 177:213\u2013224","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4699_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/13548506.2014.936886","volume":"20","author":"J Boyle","year":"2015","unstructured":"Boyle J, Vukicevic M, Koklanis K et al (2015) Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review. Psychol Health Med 20(3):296\u2013310","journal-title":"Psychol Health Med"},{"issue":"10","key":"4699_CR18","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00417-016-3384-0","volume":"254","author":"H Senra","year":"2016","unstructured":"Senra H, Ali Z, Balaskas K et al (2016) Psychological impact of anti-VEGF treatments for wet macular degeneration-a review. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 254(10):1873\u20131880","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"3","key":"4699_CR19","first-page":"445","volume":"82","author":"N Moerman","year":"1996","unstructured":"Moerman N, van Dam FS, Muller MJ et al (1996) The Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anesth Analg 82(3):445\u2013451","journal-title":"Anesth Analg"},{"key":"4699_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1477-7525-11-166","volume":"11","author":"A Maurice-Szamburski","year":"2013","unstructured":"Maurice-Szamburski A, Loundou A, Capdevila X et al (2013) Validation of the French version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Health Qual Life Outcomes 11:166","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"4699_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jfo.2016.11.028","volume":"40","author":"Y Gayadine-Harricham","year":"2017","unstructured":"Gayadine-Harricham Y, Amzallag T (2017) Prevalence and causes of pain after cataract surgery: comparison of 1st and 2nd eyes. J Fr Ophtalmol 40(6):505\u2013511","journal-title":"J Fr Ophtalmol"},{"issue":"7\u20138","key":"4699_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.annfar.2011.03.010","volume":"30","author":"J-M Wattier","year":"2011","unstructured":"Wattier J-M, Barreau O, Devos P et al (2011) Measure of preoperative anxiety and need for information with six issues. Ann Fr Anesth Reanim 30(7\u20138):533\u2013537","journal-title":"Ann Fr Anesth Reanim"},{"issue":"4","key":"4699_CR23","first-page":"176","volume":"30","author":"J-K Wang","year":"2015","unstructured":"Wang J-K, Huang T-L, Su P-Y et al (2015) An updated review of long-term outcomes from randomized controlled trials in approved pharmaceuticals for diabetic macular edema. Eye Sci 30(4):176\u2013183","journal-title":"Eye Sci"},{"issue":"2","key":"4699_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/aos.12802","volume":"94","author":"O Segal","year":"2016","unstructured":"Segal O, Segal-Trivitz Y, Nemet AY et al (2016) Anxiety levels and perceived pain intensity during intravitreal injections. Acta Ophthalmol 94(2):203\u2013204","journal-title":"Acta Ophthalmol"},{"key":"4699_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/OPTH.S24358","volume":"5","author":"R Tailor","year":"2011","unstructured":"Tailor R, Beasley R, Yang Y et al (2011) Evaluation of patients\u2019 experiences at different stages of the intravitreal injection procedure - what can be improved? Clin Ophthalmol Auckl NZ 5:1499\u20131502","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"4","key":"4699_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/IAE.0b013e3182252ad3","volume":"32","author":"L Rifkin","year":"2012","unstructured":"Rifkin L, Schaal S (2012) Factors affecting patients\u2019 pain intensity during in office intravitreal injection procedure. Retina Phila Pa 32(4):696\u2013700","journal-title":"Retina Phila Pa"},{"issue":"7","key":"4699_CR27","first-page":"939","volume":"127","author":"PYS Chua","year":"2009","unstructured":"Chua PYS, Mitrut I, Armbrecht A-M et al (2009) Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration. Arch Ophthalmol Chic Ill 1960 127(7):939\u2013940","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"3","key":"4699_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ajo.2006.03.042","volume":"142","author":"DB Roth","year":"2006","unstructured":"Roth DB, Scott IU, Gulati N et al (2006) Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection. Am J Ophthalmol 142(3):492\u2013494","journal-title":"Am J Ophthalmol"},{"key":"4699_CR29","first-page":"Doc01","volume":"4","author":"H Berth","year":"2007","unstructured":"Berth H, Petrowski K, Balck F (2007) The Amsterdam Preoperative Anxiety and Information Scale (APAIS) - the first trial of a German version. Psycho-Soc Med 4:Doc01","journal-title":"Psycho-Soc Med"},{"issue":"12","key":"4699_CR30","doi-asserted-by":"publisher","first-page":"e81042","DOI":"10.1371\/journal.pone.0081042","volume":"8","author":"RP Finger","year":"2013","unstructured":"Finger RP, Fenwick E, Hirneiss CW et al (2013) Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences. PLoS One 8(12):e81042","journal-title":"PLoS One"},{"issue":"6","key":"4699_CR31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ophtha.2013.12.032","volume":"121","author":"RP Finger","year":"2014","unstructured":"Finger RP, Guymer RH, Gillies MC et al (2014) The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. Ophthalmology. 121(6):1246\u20131251","journal-title":"Ophthalmology."},{"issue":"1","key":"4699_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/APO.0b013e31827be8b1","volume":"2","author":"WJ Lee","year":"2013","unstructured":"Lee WJ, Cho HY, Kim DH et al (2013) Depression of late age-related macular degeneration patients in Korea. Asia-Pac J Ophthalmol Phila Pa 2(1):23\u201327","journal-title":"Asia-Pac J Ophthalmol Phila Pa"},{"issue":"4","key":"4699_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/archophthalmol.2010.24","volume":"128","author":"R Casten","year":"2010","unstructured":"Casten R, Rovner BW, Leiby BE et al (2010) Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration. Arch Ophthalmol Chic Ill 1960 128(4):506\u2013508","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"4699_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12968\/ijop.2010.1.2.68","volume":"1","author":"K Henriksen","year":"2010","unstructured":"Henriksen K, Adhami S (2010) Patient experience of intravitreal injections in AMD. Int J Ophthalmic Pract 1:68\u201372","journal-title":"Int J Ophthalmic Pract"},{"key":"4699_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0264619613481778","volume":"31","author":"C Thetford","year":"2013","unstructured":"Thetford C, Hodge S, Harding S et al (2013) Living with age-related macular degeneration treatment: patient experiences of being treated with ranibizumab (Lucentis)\u00ae intravitreal injections. Br J Vis Impair 31:89\u2013101","journal-title":"Br J Vis Impair"},{"issue":"8","key":"4699_CR36","first-page":"980","volume":"28","author":"E Moisseiev","year":"2014","unstructured":"Moisseiev E, Regenbogen M, Rabinovitch T et al (2014) Evaluation of pain during intravitreal Ozurdex injections vs. intravitreal bevacizumab injections. Eye Lond Engl 28(8):980\u2013985","journal-title":"Eye Lond Engl"},{"issue":"6","key":"4699_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MCC.0b013e328315a611","volume":"14","author":"CA Rodriguez-Osorio","year":"2008","unstructured":"Rodriguez-Osorio CA, Dominguez-Cherit G (2008) Medical decision making: paternalism versus patient-centered (autonomous) care. Curr Opin Crit Care 14(6):708\u2013713","journal-title":"Curr Opin Crit Care"},{"key":"4699_CR38","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/OPTH.S108979","volume":"10","author":"A Feng","year":"2016","unstructured":"Feng A, O\u2019Neill J, Holt M et al (2016) Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations. Clin Ophthalmol Auckl NZ 10:1505\u20131511","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"9","key":"4699_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/02713683.2012.681335","volume":"37","author":"E Moisseiev","year":"2014","unstructured":"Moisseiev E, Regenbogen M, Bartfeld Y et al (2014) Evaluation of pain in intravitreal bevacizumab injections. Curr Eye Res 37(9):813\u2013817","journal-title":"Curr Eye Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04699-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T01:41:43Z","timestamp":1619660503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04699-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04699-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Baillif, Stephanie has received research grants from Allergan, Bayer, Novartis, and Horus Pharma. The other authors have no affiliation with any organization or entity with any financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study conduct was approved by the Commission Nationale Informatique et Libert\u00e9s (CNIL Number: 2004024 v 0) and was performed in accordance with the ethical standards outlined by the 1964 Helsinki Declaration and its latter amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}